Tectonic Therapeutic, Inc. (NASDAQ:tecx)
Industry: Biotechnology

Tectonic Therapeutic, Inc., a clinical stage biotechnology company focuses on the discovery and development of therapeutic proteins and antibodies to modulate the activity of G-protein-coupled receptors (GPCRs). It offers GEODe technology platform to enable the discovery and development of GPCR-targeted biologic medicines. The company's pipeline products include RXFP1 agonist, which is in ongoing phase 1a and 1b for the indication of heart failure with preserved ejection fraction; GPCR antagonist for indication of hereditary hemorrhagic telangiectasia; bi-functional GPCR modulator for indication of fibrosis; and GPCR modulators. Tectonic Therapeutic, Inc. is headquartered in Watertown, Massachusetts.

Current Quote*
Last: $23.950
Change: 1.000
Book: $Unk
Volume: 197,697

As Of: 05/20 15:25 ET
*Quotes delayed by 20min.

BuyIns.Net Alerts for Symbol TECX

Graphs for TECX


3 Month Graph


6 Month Graph


1 Year Graph